Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain

EMBO Journal

Volumn 21, Issue 11, 2002, Pages 2715-2723

  Dorr, Alexander ^a   Kiermer, Veronique ^a   Pedal, Angelika ^a   Rackwitz, Hans Richard ^a   Henklein, Peter ^a   Schubert, Ulrich ^a   Zhou, Ming Ming ^a   Verdin, Eric ^a   Ott, Melanie ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Acetylation; Bromodomain; HIV; PCAF; Tat

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; STRUCTURE ANALYSIS; SURFACE PROPERTY; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ACETYLTRANSFERASES; BLOTTING, WESTERN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE PRODUCTS, TAT; GREEN FLUORESCENT PROTEINS; HELA CELLS; HISTONE ACETYLTRANSFERASES; HUMANS; LUCIFERASES; LUMINESCENT PROTEINS; LYSINE; PEPTIDES; PLASMIDS; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0037013851     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/21.11.2715     Document Type: Article

References (30)

1. Activation of integrated provirus requires histone acetyltransferase, p300 and P/CAF are coactivators for HIV-1 Tat
2. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity
3. Nuclear receplor coactivator ACTR is a novel histone acetylransferase and forms a multimeric activation complex with P/CAF and CBP/p300
4. A human RNA polymerase 11 complex containing factors that modify chromatin structure
5. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase 11 holoenzyme
6. HIV-1 auxiliary proteins: Making connections in a dying cell
7. Structure and ligand of a hislone acetyltransferase bromodomain
8. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency
9. HIV-1 Tat: Coping with negative elongation factors
10. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein EIA
11. Interaction of human immuno-deficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein
12. 11250 double bromodomain module
13. The bromodomain revisited
14. Tackling Tat
15. HIV-1 Tat transcriptional activity is regulated by acetylation
16. Acetylation: A regulatory modification to rival phosphorylation?
17. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
18. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter
19. Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain
20. The transcriptional coactivators p300 and CBP are histone acetyltransferases
21. Histone-like TAFs within the PCAF histone acetylase complex
22. Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity
23. Activation of PPARγ coactivator-1 through transcription factor docking
24. Transactivation of cellular genes by human retroviruses
25. The language of covalent histone modifications
26. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
27. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
28. Specific binding of RNA polymerase 11 to the human immunodeficiency virus transactivating region RNA is regulated by cellular cofactors and Tat
29. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase 11 for function
30. A p300/CBP-associated factor that competes with the adenoviral uncoprotein EIA